H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 9.6% of adults in Jersey City have diagnosed diabetes — 2.4 points below the U.S. 12% figure. Census population 292,449. New Jersey Medicare wound biologics: Novitas Solutions (JL). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Jersey City clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Jersey City storefront.
PRP Wound Care Technology in Jersey City, NJ for clinics & physicians. PRP wound care accelerates healing… Compliance support & pricing — contact Hawk Medical.
Copy-pasting a First Coast (Florida) LCD into a New Jersey chart is a denial pattern. You are JL. CDC PLACES (2023, crude) estimates 9.6% of adults in Jersey City have diagnosed diabetes — 2.4 points below the U.S. 12% figure. Use New Jersey Department of Health for community education; use the IFU for the product in the fridge. prp wound care is the SKU conversation, not a patient appointment book.
National PRP Wound Care Technology notes (how the product actually works)Three grains, kept separate on purpose. City: Census 292,449 and CDC PLACES crude rates. State: New Jersey Department of Health, Diabetes Belt not in the core list. Federal: 21 CFR 1271 and Novitas Solutions LCDs. CDC PLACES (2023, crude) estimates 9.6% of adults in Jersey City have diagnosed diabetes — 2.4 points below the U.S. 12% figure.
Named person, real rates, no fake address. Joe Bradley, founder, active practice owner. CDC PLACES (2023, crude) estimates 9.6% of adults in Jersey City have diagnosed diabetes — 2.4 points below the U.S. 12% figure. Adult arthritis here is 14.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Schema on this site does not publish a fabricated star rating for Jersey City.
CDC PLACES (2023, crude prevalence) estimates 9.6% of adults — 2.4 points below the U.S. 12% figure. Obesity is 26.2%; arthritis is 14.6%. That is place-level BRFSS modeling, not a clinic census and not a Jersey City trial.
New Jersey is in CMS MAC JL, administered by Novitas Solutions. CTP and skin-substitute coverage is written at the MAC level. Confirm the current LCD/article before you set utilization — we help practices map product to those rules; we do not override them.
No. They are B2B distribution pages for licensed providers. Patients in Jersey City should speak with their clinician, not use a distributor URL as care instructions.
Often yes, which is the point of vendor consolidation. Keep DME delivery tickets and HCT/P lot files separate so a New Jersey audit trail stays clean.
Bring specialty, monthly wound volume, and whether you bill JL FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 9.6% diabetes and 14.6% arthritis for Jersey City — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in Jersey City, NJ.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Jersey City is JL geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Jersey City — 2.4 points below the U.S. 12% figure. Planning input, not an outcomes claim.
New Jersey Part B wound biologics follow this contractor (siblings: DC, DE, MD, PA). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Jersey City. Useful for joint-program math; still needs a diagnosis and privileging.
No Jersey City storefront. Joe Bradley is an active practice owner. prp wound care stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.